It is interesting to note that the activation of Nrf2 is involved, in addition to the above-mentioned antioxidant activity, in tumor progression and drug resistance in several types of cancers, such as papillary thyroid cancer and prostate cancer [26,27]. This evidence concerns the gene NFE2L2 and cancer.